GSK cancer, HIV drug sales lift 2025 outlook in boost for shares
(Reuters) -GSK raised its 2025 sales expectations on Wednesday, helped by double-digit growth in the...
29th October, 2025
(Reuters) -GSK raised its 2025 sales expectations on Wednesday, helped by double-digit growth in the...
29th October, 2025
By Max A. Cherney SAN FRANCISCO (Reuters) -Substrate, a small U.S. startup, said on Tuesday that it...
29th October, 2025
ZURICH (Reuters) -UBS Group on Wednesday reported a net profit attributable to shareholders of $2.48...
29th October, 2025
OSLO (Reuters) -Equinor reported a bigger-than-expected decline of 9.9% in third-quarter profits on...
29th October, 2025
FRANKFURT (Reuters) -German chemicals maker BASF on Wednesday said quarterly adjusted operating prof...
29th October, 2025
(Reuters) -British International Investment (BII), the UK's development finance institution, said on...
29th October, 2025
By Sam Li and Lewis Jackson (Reuters) -Oil prices edged up on Wednesday morning after three straight...
29th October, 2025
ABOARD AIR FORCE ONE/JERUSALEM (Reuters) -U.S. President Donald Trump said on Wednesday that a U.S.-...
29th October, 2025
(Reuters) -Seagate Technology forecast second-quarter revenue and profit above analysts' estimates o...
29th October, 2025
SEOUL (Reuters) -SK Hynix on Wednesday said it expects the global memory chip market to experience a...
29th October, 2025
By Noel Randewich (Reuters) -Nvidia was on the verge of becoming the first company worth $5 trillion...
28th October, 2025
By Jamie McGeever ORLANDO, Florida (Reuters) -Another wave of U.S. tech euphoria lifted Wall Street...
28th October, 2025